Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terri Wrin

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Current Opinion in Infectious Diseases|June 25, 2003
Practical applications of viral fitness in clinical practiceMichael Bates, Terri Wrin, Wei Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2003
Rapid evolution of the neutralizing antibody response to HIV type 1 infectionDouglas D Richman, Terri Wrin, Susan J Little, et al.
Statistics in Medicine|June 7, 2006
HIV-1 viral fitness estimation using exchangeable on subsets priors and prior model selectionChristina M R Kitchen, Robert E Weiss, Gang Liu, et al.
Journal of Virology|October 29, 2003
Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasmaThomas B Campbell, Kristina Schneider, Terri Wrin, et al.
AIDS (London, England)|September 23, 2009
Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progressionMarit J van Gils, Zelda Euler, Becky Schweighardt, et al.
The Journal of General Virology|October 2, 2009
High prevalence of neutralizing activity against multiple unrelated human immunodeficiency virus type 1 (HIV-1) subtype B variants in sera from HIV-1 subtype B-infected individuals: evidence for subtype-specific rather than strain-specific neutralizing activityMarit J van Gils, Diana Edo-Matas, Becky Schweighardt, et al.
Virology|September 30, 2008
Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificityRalph Pantophlet, Terri Wrin, Lisa A Cavacini, et al.
Virology|April 10, 2007
Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesisRalph Pantophlet, Rowena O Aguilar-Sino, Terri Wrin, et al.
Virology|July 28, 2009
Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitopeSusan Zolla-Pazner, Sandra Cohen, Abraham Pinter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 22, 2007
Development of an HIV-1 reference panel of subtype B envelope clones isolated from the plasma of recently infected individualsBecky Schweighardt, Yang Liu, Wei Huang, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Current Opinion in Infectious Diseases|June 25, 2003
Practical applications of viral fitness in clinical practiceMichael Bates, Terri Wrin, Wei Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2003
Rapid evolution of the neutralizing antibody response to HIV type 1 infectionDouglas D Richman, Terri Wrin, Susan J Little, et al.
Statistics in Medicine|June 7, 2006
HIV-1 viral fitness estimation using exchangeable on subsets priors and prior model selectionChristina M R Kitchen, Robert E Weiss, Gang Liu, et al.
Journal of Virology|October 29, 2003
Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasmaThomas B Campbell, Kristina Schneider, Terri Wrin, et al.
AIDS (London, England)|September 23, 2009
Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progressionMarit J van Gils, Zelda Euler, Becky Schweighardt, et al.
The Journal of General Virology|October 2, 2009
High prevalence of neutralizing activity against multiple unrelated human immunodeficiency virus type 1 (HIV-1) subtype B variants in sera from HIV-1 subtype B-infected individuals: evidence for subtype-specific rather than strain-specific neutralizing activityMarit J van Gils, Diana Edo-Matas, Becky Schweighardt, et al.
Virology|September 30, 2008
Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificityRalph Pantophlet, Terri Wrin, Lisa A Cavacini, et al.
Virology|April 10, 2007
Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesisRalph Pantophlet, Rowena O Aguilar-Sino, Terri Wrin, et al.
Virology|July 28, 2009
Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitopeSusan Zolla-Pazner, Sandra Cohen, Abraham Pinter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 22, 2007
Development of an HIV-1 reference panel of subtype B envelope clones isolated from the plasma of recently infected individualsBecky Schweighardt, Yang Liu, Wei Huang, et al.
Pageof 11